Scilex Holding (SCLXW) Change in Account Payables (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Change in Account Payables of $15.8 million in Q1 2026, up 794.34% quarter-over-quarter from $1.8 million in Q4 2025, and up 208.35% on a YoY basis from $5.1 million in Q1 2025.

Scilex Holding (SCLXW) Change in Account Payables (2022 - 2026) Analysis & Trends

Scilex Holding's Change in Account Payables history runs 5 years deep, the most recent figure standing at $15.8 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 208.35% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $23.8 million (up 111.0% YoY), while the FY2025 annual figure was $13.1 million, up 76.86% from the prior year.
  • Change in Account Payables was $15.8 million for Q1 2026 at Scilex Holding, up from $1.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $15.8 million in Q1 2026 to a low of -$612000.0 in Q2 2024.
  • Historically, Change in Account Payables has averaged $3.5 million across 5 years, with a median of $2.0 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 5313.66% in 2023, then sank 126.23% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$161000.0 in 2022, then soared by 5313.66% to $8.4 million in 2023, then plunged by 38.61% to $5.2 million in 2024, then sank by 65.69% to $1.8 million in 2025, then soared by 794.34% to $15.8 million in 2026.
  • The last three Change in Account Payables figures came in at $15.8 million (Q1 2026), $1.8 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 571.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -67.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 409.00 Mn
10 Scilex Holding - - 4.15 Mn 15.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.81 Mn
Mar 31, 2026 15.81 Mn
Dec 31, 2025 1.77 Mn
Dec 31, 2025 1.77 Mn
Sep 30, 2025 4.50 Mn
Sep 30, 2025 4.50 Mn
Jun 30, 2025 1.73 Mn
Jun 30, 2025 1.73 Mn
Mar 31, 2025 5.13 Mn
Mar 31, 2025 5.13 Mn
Dec 31, 2024 5.15 Mn
Dec 31, 2024 5.15 Mn
Sep 30, 2024 1.61 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 -612,000.00
Jun 30, 2024 -612,000.00
Mar 31, 2024 1.27 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 8.39 Mn
Dec 31, 2023 8.39 Mn